HK1096555A1 - Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase -13 - Google Patents

Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase -13

Info

Publication number
HK1096555A1
HK1096555A1 HK07103852.4A HK07103852A HK1096555A1 HK 1096555 A1 HK1096555 A1 HK 1096555A1 HK 07103852 A HK07103852 A HK 07103852A HK 1096555 A1 HK1096555 A1 HK 1096555A1
Authority
HK
Hong Kong
Prior art keywords
galactosyltransferase
expression
products derived
tissue products
functional alpha
Prior art date
Application number
HK07103852.4A
Other languages
English (en)
Chinese (zh)
Inventor
David Ayares
Paul Rohricht
Original Assignee
Revivicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revivicor Inc filed Critical Revivicor Inc
Publication of HK1096555A1 publication Critical patent/HK1096555A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knockout animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3695—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A01K2267/025—Animal producing cells or organs for transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
HK07103852.4A 2004-03-17 2007-04-12 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase -13 HK1096555A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55389504P 2004-03-17 2004-03-17
US55981604P 2004-04-06 2004-04-06
PCT/US2005/008838 WO2005089411A2 (fr) 2004-03-17 2005-03-17 Produits de tissus derives d'animaux depourvus d'expression de l'alpha 1,3 galactosyltransferase fonctionnelle

Publications (1)

Publication Number Publication Date
HK1096555A1 true HK1096555A1 (en) 2007-06-08

Family

ID=34994326

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07103852.4A HK1096555A1 (en) 2004-03-17 2007-04-12 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase -13

Country Status (12)

Country Link
US (4) US8106251B2 (fr)
EP (2) EP1734814B1 (fr)
JP (4) JP2007529278A (fr)
KR (1) KR20070002057A (fr)
CN (1) CN104721883A (fr)
AU (2) AU2005223617A1 (fr)
CA (2) CA2857051A1 (fr)
DK (1) DK1734814T3 (fr)
ES (2) ES2680569T3 (fr)
HK (1) HK1096555A1 (fr)
NZ (1) NZ549953A (fr)
WO (1) WO2005089411A2 (fr)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2533259C (fr) * 2003-07-21 2014-01-28 Lifecell Corporation Matrices de tissus acellulaires realisees a partir de tissus deficitaires en galactose .alpha.-1,3-galactose
DK1734814T3 (en) 2004-03-17 2015-04-07 Revivicor Inc Tissue DERIVED FROM ANIMALS IS MISSING ANY EXPRESSION OF FUNCTIONAL ALPHA-1,3 galactosyltransferase
JP2007530242A (ja) * 2004-03-29 2007-11-01 メイヨ フオンデーシヨン フオー メデイカル エジユケーシヨン アンド リサーチ 遺伝子操作した心臓弁の異種移植片
EP3138403A1 (fr) * 2005-08-09 2017-03-08 Revivicor, Inc. Ongulés transgéniques exprimant la ctla4-ig et leurs utilisations
BRPI0714877A2 (pt) * 2006-07-31 2013-07-02 Organogenesis Inc mastopexia e pràteses de reconstruÇço de mama processo
CN101616698A (zh) 2006-10-23 2009-12-30 库克生物科技公司 组分特性增强的处理的ecm材料
WO2008059244A2 (fr) 2006-11-16 2008-05-22 University Of Leeds Préparation de tissu pour une implantation méniscale
US7980000B2 (en) 2006-12-29 2011-07-19 Applied Materials, Inc. Vapor dryer having hydrophilic end effector
US20080260794A1 (en) * 2007-02-12 2008-10-23 Lauritzen Nels J Collagen products and methods for producing collagen products
JP5538217B2 (ja) * 2007-07-10 2014-07-02 ライフセル コーポレーション 組織修復用無細胞組織基質構成体
US20100297766A1 (en) * 2008-02-04 2010-11-25 Hai-Qing Xian Method of Removing Undesired Tissue from Connective Tissue
US8709096B2 (en) * 2008-04-29 2014-04-29 Proxy Biomedical Limited Tissue repair implant
US9020577B2 (en) * 2008-05-29 2015-04-28 Yale University Systems, devices and methods for cartilage and bone grafting
US9150318B1 (en) * 2009-01-02 2015-10-06 Lifecell Corporation Method for sterilizing an acellular tissue matrix
SG176931A1 (en) 2009-07-02 2012-01-30 Lifecell Corp Device and method for treatment of incision or hernia
US10478168B2 (en) 2009-07-02 2019-11-19 Lifecell Corporation Device and method for treatment of incision or hernia
US8986377B2 (en) 2009-07-21 2015-03-24 Lifecell Corporation Graft materials for surgical breast procedures
CA2771299C (fr) * 2009-08-14 2021-02-16 Revivicor, Inc. Cochons multi-transgeniques pour le traitement du diabete
CN102481390B (zh) * 2009-09-02 2017-03-08 生命细胞公司 源自无细胞组织基质的血管移植物
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
US20110135706A1 (en) * 2009-12-03 2011-06-09 Lifecell Corporation Nerve treatment devices and methods
EP2575674A4 (fr) * 2010-05-24 2014-08-20 Mayo Foundation Dispositifs médicaux comprenant de l'acier inoxydable duplex
CA2808478C (fr) * 2010-09-27 2015-10-06 University Of Leeds Produits vasculaires acellulaires
WO2012088501A2 (fr) 2010-12-23 2012-06-28 Mayo Foundation For Medical Education And Research Appareil, systèmes et méthodes de dissection et de prélèvement de vaisseaux sanguins
SG10201802843WA (en) * 2011-04-28 2018-05-30 Lifecell Corp Method for enzymatic treatment of tissue products
US9238793B2 (en) * 2011-04-28 2016-01-19 Lifecell Corporation Method for enzymatic treatment of tissue products
US10207025B2 (en) * 2011-04-28 2019-02-19 Lifecell Corporation Method for enzymatic treatment of tissue products
US20130123647A1 (en) 2011-05-03 2013-05-16 The Research Foundation Of State University Of New York Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections
PL2709445T3 (pl) 2011-05-16 2019-01-31 The Curators Of The University Of Missouri Zwierzęta odporne na wirus zespołu rozrodczo-oddechowego świń
KR20140045398A (ko) * 2011-06-30 2014-04-16 시그마-알드리치 컴퍼니., 엘엘씨 Cmp-n-아세틸뉴라민산 하이드록실라제 및/또는 당단백질 알파-1,3-갈락토실트랜스퍼라제가 결핍된 세포
KR101446265B1 (ko) * 2011-10-17 2014-11-03 메디칸(주) 면역성이 제거된 생체지방소재 및 이의 제조방법
US9549812B2 (en) 2012-01-13 2017-01-24 Lifecell Corporation Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses
BR112014026090A8 (pt) 2012-04-24 2019-08-27 Lifecell Corp composição de matriz tecidual apta a fluir
BR112014031707A2 (pt) 2012-06-21 2017-06-27 Lifecell Corp prótese; método para fabricar uma prótese implantável; e método para tratamento
CA2884311C (fr) 2012-10-04 2021-02-16 Lifecell Corporation Modele chirurgical et dispositif de pose
US20140115728A1 (en) 2012-10-24 2014-04-24 A. Joseph Tector Double knockout (gt/cmah-ko) pigs, organs and tissues
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US10016528B2 (en) * 2013-09-09 2018-07-10 Eran Rosines Biologic prosthesis and methods of production and use
WO2015066668A1 (fr) 2013-11-04 2015-05-07 Lifecell Corporation Procédé d'élimination d'alpha-galactose
US20170182208A1 (en) * 2014-03-28 2017-06-29 Vita Threads,Llc Absorbable fibrin microthread sutures for reduced inflammation and scarring in tissue ligation
CA2954191A1 (fr) * 2014-07-30 2016-02-04 Lifecell Corporation Procedes de selection de tissus appropries a l'age
US9888673B2 (en) 2014-12-10 2018-02-13 Regents Of The University Of Minnesota Genetically modified cells, tissues, and organs for treating disease
US11246299B2 (en) 2015-03-04 2022-02-15 Pormedtec Co., Ltd. Disease model pig exhibiting stable phenotype, and production method thereof
AU2016265286B2 (en) 2015-05-15 2021-01-21 Lifecell Corporation Tissue matrices for plastic surgery
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
JP2018525000A (ja) 2015-08-06 2018-09-06 ザ・キュレーターズ・オブ・ザ・ユニバーシティ・オブ・ミズーリＴｈｅ Ｃｕｒａｔｏｒｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍｉｓｓｏｕｒｉ 改変ｃｄ１６３遺伝子を有する病原体抵抗性動物
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
AU2016310471B2 (en) 2015-08-21 2021-05-20 Lifecell Corporation Breast treatment device
ITUB20156019A1 (it) * 2015-11-30 2017-05-30 Biocompatibility Innovation Soc A Responsabilita Limitata Semplificata Metodo per l'inattivazione di xenoantigeni in tessuti biologici
WO2017127228A1 (fr) * 2016-01-22 2017-07-27 Aperion Biologics Inc. Xénogreffes de tissus conjonctifs denses réguliers
WO2017127227A1 (fr) * 2016-01-22 2017-07-27 Aperion Biologics Inc. Biomatériau pour xénogreffes
US11913061B2 (en) 2016-07-08 2024-02-27 Kao Corporation Method for preparing nucleic acid sample
KR20190045207A (ko) 2016-08-31 2019-05-02 라이프셀 코포레이션 유방 치료 장치
MX2019005172A (es) * 2016-11-02 2019-09-26 Axogen Corp Injertos de tejido amniotico y metodos para preparar y usar los mismos.
US10413634B2 (en) 2017-01-30 2019-09-17 Lifecell Corporation Transglutaminase treated products
JP2020513944A (ja) 2017-01-30 2020-05-21 ライフセル コーポレーションＬｉｆｅＣｅｌｌ Ｃｏｒｐｏｒａｔｉｏｎ 組織マトリックス材料および酵素接着剤
CN110546267A (zh) * 2017-02-01 2019-12-06 哈佛学院董事及会员团体 提高细胞基因编辑效率的方法
WO2018157011A1 (fr) * 2017-02-24 2018-08-30 Xenotherapeutics, Inc. Produits et méthodes pour le traitement de brûlures
WO2019006430A1 (fr) * 2017-06-30 2019-01-03 Vascudyne Inc Implants en tissu régénératif et en tissu naturel
KR102019992B1 (ko) * 2017-09-22 2019-09-11 대한민국 이소글로보트리헥소실세라마이드 신타제 넉아웃 세포주, 및 이를 이용한 복제난자 및 형질전환 동물
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
US10821205B2 (en) 2017-10-18 2020-11-03 Lifecell Corporation Adipose tissue products and methods of production
EP3697462B1 (fr) 2017-10-19 2023-07-12 LifeCell Corporation Produits de matrice tissulaire acellulaire fluides et procédés de production
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
EP3510861A3 (fr) * 2017-12-22 2019-09-25 Avantea SRL Produits alimentaires et médicaux hypoallergéniques issus de bétail génétiquement modifié
US11602548B1 (en) 2018-02-26 2023-03-14 Convatec, Inc Fibrous birth tissue composition and method of use
US11026980B1 (en) 2018-02-26 2021-06-08 Triad Life Sciences, Inc. Flowable birth tissue composition and related methods
US11160260B2 (en) 2018-04-17 2021-11-02 The Curators Of The University Of Missouri Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)
US10883084B2 (en) 2018-10-05 2021-01-05 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
JP7431837B2 (ja) 2018-10-05 2024-02-15 ゼノセラピューティクス インコーポレイテッド 異種移植製品及び異種移植方法
CA3115394A1 (fr) * 2018-10-10 2020-04-16 Revivicor, Inc. Compositions et methodes de prevention des allergies
CN109735480B (zh) * 2019-02-27 2021-11-12 光明乳业股份有限公司 一种合成乳酰-n-新四糖的重组枯草芽孢杆菌及其构建方法与应用
CN111635879B (zh) * 2019-03-01 2022-04-22 中国科学院天津工业生物技术研究所 L-赖氨酸高产菌株及其构建方法和应用
AU2020244827A1 (en) 2019-03-25 2021-09-30 Alexis Bio, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non- human) donor and methods and products relating to same
WO2020227095A1 (fr) 2019-05-03 2020-11-12 Lifecell Corporation Dispositif de traitement du sein
WO2020243497A1 (fr) 2019-05-30 2020-12-03 Lifecell Corporation Implant mammaire biologique
CN111657267B (zh) * 2020-06-17 2021-02-02 科瑞百奥泰州生物技术有限公司 一种用于软骨，肌腱，半月板保存的无冰晶冷冻保存液和冷冻方法
WO2022256401A1 (fr) * 2021-06-01 2022-12-08 Xenotherapeutics, Inc. Greffes nerveuses xénogéniques et procédés associés

Family Cites Families (142)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL46030A0 (en) 1974-11-11 1975-02-10 Rosenberg L Orthopaedic screw
US4011602A (en) 1975-10-06 1977-03-15 Battelle Memorial Institute Porous expandable device for attachment to bone tissue
CH625119A5 (fr) 1978-03-28 1981-09-15 Sulzer Ag
US4302855A (en) 1979-04-27 1981-12-01 Swanson Alfred B Plug for the intramedallary canal of a bone and method
GB2052267B (en) 1979-06-30 1983-06-22 Hardinge K Medullary canal plug
EP0023787B1 (fr) 1979-07-25 1983-07-20 University Of Exeter Bouchons pour le canal médullaire d'un os
US4293962A (en) 1980-02-14 1981-10-13 Zimmer Usa, Inc. Bone plug inserting system
CH648477A5 (de) 1981-02-18 1985-03-29 Sulzer Ag Spreizbare markraumsperre.
US4409974A (en) 1981-06-29 1983-10-18 Freedland Jeffrey A Bone-fixating surgical implant device
CH652912A5 (de) 1982-02-23 1985-12-13 Sulzer Ag Den schaft einer in einen roehrenknochen einsetzbaren endoprothese zentrierende halterung.
US4454875A (en) 1982-04-15 1984-06-19 Techmedica, Inc. Osteal medical staple
US4801299A (en) 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
SE459844B (sv) 1983-08-12 1989-08-14 Idea Ab Anordning foer fixering av en ledprotes
US4697584A (en) 1984-10-12 1987-10-06 Darrel W. Haynes Device and method for plugging an intramedullary bone canal
US4686973A (en) 1984-10-12 1987-08-18 Dow Corning Corporation Method of making an intramedullary bone plug and bone plug made thereby
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US4627434A (en) 1985-05-03 1986-12-09 Murray William M Bone cement system and method
US4863852A (en) 1985-07-03 1989-09-05 Virginia Tech Intellectual Properties, Inc. Method of detecting, isolating and purifying clostridium difficile toxin A and its receptors
US4755593A (en) 1985-07-24 1988-07-05 Lauren Mark D Novel biomaterial of cross-linked peritoneal tissue
CH667801A5 (de) 1985-10-10 1988-11-15 Sulzer Ag In einen roehrenknochen einsetzbare markraumsperre.
US4738255A (en) 1986-04-07 1988-04-19 Biotron Labs, Inc. Suture anchor system
US4994384A (en) 1986-12-31 1991-02-19 W. R. Grace & Co.-Conn. Multiplying bovine embryos
US4834757A (en) 1987-01-22 1989-05-30 Brantigan John W Prosthetic implant
US5057420A (en) 1987-06-05 1991-10-15 Granada Biosciences, Inc. Bovine nuclear transplantation
US5108438A (en) 1989-03-02 1992-04-28 Regen Corporation Prosthetic intervertebral disc
US5007934A (en) 1987-07-20 1991-04-16 Regen Corporation Prosthetic meniscus
US5681353A (en) 1987-07-20 1997-10-28 Regen Biologics, Inc. Meniscal augmentation device
US5306311A (en) 1987-07-20 1994-04-26 Regen Corporation Prosthetic articular cartilage
US4880429A (en) 1987-07-20 1989-11-14 Stone Kevin R Prosthetic meniscus
CH674306A5 (fr) 1988-01-14 1990-05-31 Sulzer Ag
JPH01230353A (ja) 1988-03-09 1989-09-13 Aisin Seiki Co Ltd セツテイングガイド付人工股関節用ステム
ATE79239T1 (de) 1988-04-22 1992-08-15 Mathys Ag Markraumsperre.
US5015247A (en) 1988-06-13 1991-05-14 Michelson Gary K Threaded spinal implant
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US4956178A (en) 1988-07-11 1990-09-11 Purdue Research Foundation Tissue graft composition
US5354768A (en) 1988-07-26 1994-10-11 Sankyo Company, Limited Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
BR8907666A (pt) 1988-09-21 1991-07-30 Cambridge Animal Biotech Derivacao de linhas de celulas embrionarias pluripotenciais de animais domesticos
US4961740B1 (en) 1988-10-17 1997-01-14 Surgical Dynamics Inc V-thread fusion cage and method of fusing a bone joint
US5078746A (en) 1989-01-25 1992-01-07 Richards Medical Company Femoral stem distal centralizer
US4944384A (en) 1989-01-30 1990-07-31 Hay & Forage Industries Trash discharge apparatus for crop transferring conveyor mechanism
US5061287A (en) 1989-02-13 1991-10-29 Feiler Frederic C Proximal cement sealing plug for hip prosthesis
US5175383A (en) 1989-02-17 1992-12-29 President And Fellows Of Harvard College Animal model for benign prostatic disease
DE8904664U1 (fr) 1989-04-13 1989-06-01 Rehau Ag + Co, 8673 Rehau, De
US4997384A (en) 1989-04-17 1991-03-05 Otis Engineering Corporation Wet connector
US5324663A (en) 1990-02-14 1994-06-28 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
US5092891A (en) 1990-03-08 1992-03-03 Kummer Frederick J Cement plug for the medullary canal of a bone and coacting tool for installing same
WO1991018088A1 (fr) 1990-05-23 1991-11-28 The United States Of America, Represented By The Secretary, United States Department Of Commerce Vecteurs eucaryotiques a base de virus adeno-associes (aav)
US5236445A (en) 1990-07-02 1993-08-17 American Cyanamid Company Expandable bone anchor and method of anchoring a suture to a bone
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5147402A (en) 1990-12-05 1992-09-15 Sulzer Brothers Limited Implant for ingrowth of osseous tissue
US5192327A (en) 1991-03-22 1993-03-09 Brantigan John W Surgical prosthetic implant for vertebrae
US5281422A (en) 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5263991A (en) 1992-10-21 1993-11-23 Biomet, Inc. Method for heating biocompatible implants in a thermal packaging line
US5589582A (en) 1992-10-27 1996-12-31 Biotransplant, Inc. Polynucleotides en coding porcine cytokines
IL104313A0 (en) 1993-01-06 1993-05-13 Bromberg A & Co Ltd Device for fixing a prosthesis to a bone
JPH08510636A (ja) 1993-01-20 1996-11-12 バイオトランスプラント，インコーポレイテッド 多重翻訳開始部位から多量体タンパク質を発現出来るレトロウイルスベクター
US5496720A (en) 1993-02-10 1996-03-05 Susko-Parrish; Joan L. Parthenogenic oocyte activation
JPH06253856A (ja) 1993-02-26 1994-09-13 Amano Pharmaceut Co Ltd ムタロターゼ遺伝子
EP1621627A3 (fr) 1993-03-16 2006-06-07 The Austin Research Institute Utilisation de gal$g(a) (1,3) galactosyl-transferase porcine dans le traitement de xenogreffes
US6331658B1 (en) 1993-04-20 2001-12-18 Integris Baptist Medical Center, Inc. Genetically engineered mammals for use as organ donors
GB9308271D0 (en) 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
US5383932A (en) 1993-04-27 1995-01-24 Johnson & Johnson Professional, Inc. Absorbable medullary plug
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
WO1995020661A1 (fr) 1994-01-27 1995-08-03 Bresatec Ltd. Procedes et substances destines a la prise en charge du rejet hyperaigu suite a une heterogreffe chez l'homme
US5849991A (en) 1994-01-27 1998-12-15 Bresatch Limited Mice homozygous for an inactivated α 1,3-galactosyl transferase gene
DE69535752D1 (de) 1994-04-13 2008-06-26 Biotransplant Inc Alpha(1,3)galactosyltransferase-negatives schwein
US5714353A (en) 1994-05-24 1998-02-03 Research Corporation Technologies, Inc. Safe vectors for gene therapy
US5479033A (en) 1994-05-27 1995-12-26 Sandia Corporation Complementary junction heterostructure field-effect transistor
JPH10504707A (ja) 1994-06-15 1998-05-12 アレクション・ファーマシューティカル・インク 異種移植片の超急性拒否反応を減少させる方法
US5850004A (en) 1994-08-02 1998-12-15 Cornell Research Foundation, Inc. Transgenic mouse deficient in inducible nitric oxide synthase
AU711183B2 (en) 1994-08-19 1999-10-07 Biotransplant Incorporated Genetically engineered swine cells
US5922601A (en) 1995-01-19 1999-07-13 Biotransplant, Inc. High efficiency gene trap selection of regulated genetic loci
WO1996028967A1 (fr) 1995-03-17 1996-09-26 Chihiro Koike Mammiferes transgeniques autres que des primates, ou des serotypes de primates superieurs ont ete exprimes par un transfert de genes etrangers et procede pour creer ceux-ci
US6610288B1 (en) 1995-05-26 2003-08-26 Diacrin, Inc. Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function
US5913900A (en) 1995-06-07 1999-06-22 Corsscart, Inc. Substantially native meniscal cartilage heterografts
US5962644A (en) 1995-06-07 1999-10-05 Biotransplant, Inc. Porcine CD34
US5865849A (en) 1995-06-07 1999-02-02 Crosscart, Inc. Meniscal heterografts
US6231608B1 (en) 1995-06-07 2001-05-15 Crosscart, Inc. Aldehyde and glycosidase-treated soft and bone tissue xenografts
US5984858A (en) 1995-06-07 1999-11-16 Crosscart, Inc. Meniscal xenografts
US5902338A (en) 1995-09-15 1999-05-11 Crosscart, Inc. Anterior cruciate ligament heterograft
US5944755A (en) 1995-09-15 1999-08-31 Crosscart, Inc. Articular cartilage xenografts
US6110206A (en) 1995-09-15 2000-08-29 Crosscart, Inc. Anterior cruciate ligament xenografts
US5856106A (en) 1995-11-01 1999-01-05 Biotransplant, Inc. Determination of antibody production against administered therapeutic glycoproteins, especially monoclonal antibodies
EP0877549A4 (fr) 1995-11-03 2002-01-02 Mount Sinai Medical Ct Procedes et compositions de reduction du rejet de xenogreffe
DE69738177T2 (de) 1996-08-02 2008-07-03 The Austin Research Institute, Heidelberg Verbesserte nukleinsäuren, welche für eine chimäre glycosyltransferase kodieren
EP0959899B9 (fr) 1996-08-16 2009-10-21 Biotransplant, Inc ANTICORPS LO-CD2a ET SON UTILISATION POUR INHIBER L'ACTIVATION ET LA PROLIFERATION DE CELLULES T
NZ334016A (en) 1996-08-19 2000-08-25 Univ Massachusetts Embryonic stem cell lines produced by cross species nuclear transplantation
AUPO182396A0 (en) 1996-08-23 1996-09-12 Austin Research Institute, The Improved nucleic acids for reducing carbohydrate epitopes
US6136566A (en) 1996-10-04 2000-10-24 Lexicon Graphics Incorporated Indexed library of cells containing genomic modifications and methods of making and utilizing the same
US6455037B1 (en) 1996-11-01 2002-09-24 Mount Sinai School Of Medicine Of The City University Of New York Cells expressing an αgala nucleic acid and methods of xenotransplantation
US6235969B1 (en) 1997-01-10 2001-05-22 University Of Massachusetts Cloning pigs using donor nuclei from non-quiescent differentiated cells
WO2000006194A2 (fr) 1997-02-05 2000-02-10 Biotransplant, Inc. Depletion de cellules responsables du rejet d'une greffe induit par des anticorps
CA2279544A1 (fr) 1997-02-05 1998-08-06 Biotransplant Incorporated Induction d'une tolerance aux cellules b
US5935169A (en) 1997-02-13 1999-08-10 Chan; Kwan-Ho Bone cement plug for deployment in a bone canal
NZ500007A (en) 1997-03-26 2001-08-31 Imp College Innovations Ltd Anticoagulant fusion protein anchored to cell membrane to prevent organ rejection after a transplant
AU8828898A (en) 1997-08-13 1999-03-08 Biotransplant Incorporated Porcine stem cell factor varients and recombinant cells expressing such polypeptides
WO1999009141A1 (fr) 1997-08-14 1999-02-25 Biotransplant, Inc. Cellules totipotentes porcines et procede de culture a long terme
AU750025B2 (en) 1997-09-26 2002-07-11 Athersys, Inc. Expression of endogenous genes by non-homologous recombination of a vector construct with cellular DNA
US6482937B1 (en) 1997-10-09 2002-11-19 Biotransplant, Inc. Porcine Oct-4 promoter
AU1581899A (en) 1997-10-28 1999-05-17 Biotransplant Incorporated Nuclear transfer for production of transgenic animal embryo
EP1059891A4 (fr) 1998-03-06 2004-05-19 Crosscart Inc Xenogreffes de tissus mous
US20030039678A1 (en) 1998-03-16 2003-02-27 Stone Kevin R. Xenograft bone matrix for orthopedic applications
WO1999047080A1 (fr) 1998-03-16 1999-09-23 Crosscart, Inc. Xenogreffes osseuses
US6383732B1 (en) 1999-02-11 2002-05-07 Crosscart, Inc. Method of preparing xenograft heart valves
SK287538B6 (sk) 1998-03-20 2011-01-04 Commonwealth Scientific And Industrial Research Organisation Syntetický gén obsahujúci dispergovanú alebo cudzorodú deoxyribonukleovú molekulu, génový konštrukt obsahujúci tento syntetický gén a prípravok obsahujúci tento syntetický gén
US6080576A (en) 1998-03-27 2000-06-27 Lexicon Genetics Incorporated Vectors for gene trapping and gene activation
WO1999051170A1 (fr) 1998-04-02 1999-10-14 Crosscart, Inc. Xenogreffes osseuses
GB9807520D0 (en) 1998-04-09 1998-06-10 Univ Wales Medicine Modified biological material
GB9809280D0 (en) 1998-04-30 1998-07-01 Rpms Technology Ltd Immunosupression
JP4341049B2 (ja) * 1998-06-05 2009-10-07 オルガノジェネシス インク． 生物工学により作成したチューブ状移植片補綴
US6395011B1 (en) 1998-07-17 2002-05-28 Johnson & Johnson Method and apparatus for harvesting and implanting bone plugs
AU5682999A (en) 1998-08-18 2000-03-14 Biotransplant Incorporated Molecular sequence of swine retrovirus and methods of use
AU5575899A (en) 1998-08-20 2000-03-14 Biotransplant Incorporated Inbred mhc-homozygous miniature swine and uses thereof
NL1010539C2 (nl) 1998-11-12 2000-05-15 Petrus Tarasius Josephus Spier Botplug.
GB9825555D0 (en) 1998-11-20 1999-01-13 Imp College Innovations Ltd Suppression of xenotransplant rejection
US6258998B1 (en) 1998-11-24 2001-07-10 Infigen, Inc. Method of cloning porcine animals
US6700037B2 (en) 1998-11-24 2004-03-02 Infigen, Inc. Method of cloning porcine animals
US6267786B1 (en) 1999-02-11 2001-07-31 Crosscart, Inc. Proteoglycan-reduced soft tissue xenografts
US20030068815A1 (en) 1999-02-11 2003-04-10 Stone Kevin R. Sterilized xenograft tissue
ES2338631T3 (es) 1999-03-04 2010-05-11 Revivicor, Inc. Modificacion genetica de celulas somaticas y usos de las mismas.
CA2385162A1 (fr) 1999-09-30 2001-04-05 William L. Fodor Compositions et methodes pouvant modifier l'expression genique
US6494883B1 (en) 2000-05-26 2002-12-17 Bret A. Ferree Bone reinforcers
CA2426669A1 (fr) 1999-10-22 2001-05-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Gene et promoteur de la galactosyltransferase-.alpha.1-3
ES2749801T3 (es) 1999-12-22 2020-03-23 Acell Inc Composición para regeneración de tejidos
US20030097179A1 (en) 2000-01-11 2003-05-22 Carter Kevin C. Materials and methods for improved bone tendon bone transplantation
US20030023304A1 (en) 2000-01-11 2003-01-30 Carter Kevin C. Materials and methods for improved bone tendon bone transplantation
US6632246B1 (en) 2000-03-14 2003-10-14 Chondrosite, Llc Cartilage repair plug
EP1278559B1 (fr) * 2000-04-28 2008-03-26 Baylor College Of Medicine Prostheses vasculaires decellularisees
EP1315796B1 (fr) 2000-08-16 2006-07-12 Duke University Constructions de tissu decellularise issues de l'ingenierie tissulaire et tissus ainsi produits
JP4180804B2 (ja) 2001-02-07 2008-11-12 パイオニア株式会社 対物レンズ衝突防止装置及びその製造方法
AU2002242854A1 (en) 2001-03-21 2002-10-03 Geron Corporation Use of telomerase reverse transcriptase to create homozygous knockout animals
US7126039B2 (en) 2001-03-21 2006-10-24 Geron Corporation Animal tissue with carbohydrate antigens compatible for human transplantation
CA2445945A1 (fr) * 2001-04-30 2002-11-07 Rbc Biotechnology, Inc. Cellules et organes modifies destines a la xenotransplantation
US20040234507A1 (en) 2001-05-07 2004-11-25 Stone Kevin R Submucosal xenografts
EP1465481A4 (fr) * 2001-12-21 2007-09-12 Univ Missouri Porc knock-out et leurs procedes de fabrication
US6878168B2 (en) * 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
JP2005529682A (ja) 2002-06-14 2005-10-06 クロスカート インコーポレイテッド ガラクトシダーゼ処理されたプロテーゼデバイス
CA2491528A1 (fr) * 2002-06-28 2004-01-08 Cardio, Inc. Tissu decellularise
JP2005535343A (ja) 2002-08-14 2005-11-24 イマージ バイオセラピューティクス，インコーポレーテッド α（１，３）−ガラクトシルトランスフェラーゼ欠損細胞、選択する方法、およびそれらから作製されたα（１，３）−ガラクトシルトランスフェラーゼ欠損ブタ
EP1534819B1 (fr) 2002-08-21 2009-12-09 Revivicor, Inc. Porcins ne presentant aucune expression de l'alpha 1,3-galactosyltransferase fonctionnelle
CA2533259C (fr) 2003-07-21 2014-01-28 Lifecell Corporation Matrices de tissus acellulaires realisees a partir de tissus deficitaires en galactose .alpha.-1,3-galactose
DK1734814T3 (en) * 2004-03-17 2015-04-07 Revivicor Inc Tissue DERIVED FROM ANIMALS IS MISSING ANY EXPRESSION OF FUNCTIONAL ALPHA-1,3 galactosyltransferase

Also Published As

Publication number Publication date
EP1734814A2 (fr) 2006-12-27
US10912863B2 (en) 2021-02-09
US20120282226A1 (en) 2012-11-08
CA2559720A1 (fr) 2005-09-29
AU2010200421B2 (en) 2012-02-16
CN104721883A (zh) 2015-06-24
JP2007529278A (ja) 2007-10-25
US20190111180A1 (en) 2019-04-18
JP2013215615A (ja) 2013-10-24
WO2005089411A3 (fr) 2005-12-08
KR20070002057A (ko) 2007-01-04
US10130737B2 (en) 2018-11-20
DK1734814T3 (en) 2015-04-07
JP2020036923A (ja) 2020-03-12
ES2537030T3 (es) 2015-06-01
ES2680569T3 (es) 2018-09-10
AU2005223617A1 (en) 2005-09-29
EP2433492A1 (fr) 2012-03-28
EP1734814A4 (fr) 2009-08-26
WO2005089411A2 (fr) 2005-09-29
NZ549953A (en) 2010-11-26
US20150182664A1 (en) 2015-07-02
CA2857051A1 (fr) 2005-09-29
US20050260176A1 (en) 2005-11-24
US8106251B2 (en) 2012-01-31
JP2016105861A (ja) 2016-06-16
EP2433492B1 (fr) 2018-04-25
AU2010200421A1 (en) 2010-02-25
EP1734814B1 (fr) 2015-01-21

Similar Documents

Publication Publication Date Title
HK1096555A1 (en) Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase -13
GB0715203D0 (en) Skin care compositions
EP1951762A4 (fr) Préparations et méthodes pour soin de la peau amélioré
ITRM20050265A1 (it) Protesi modulare perfezionata per osteosintesi, in particolare per l'osteosintesi dell'omero.
IS7663A (is) Starfrænar hjartavöðvafrumur úr mannafósturstofnfrumum
EP1768630A4 (fr) Technique de traitement de protheses tissulaires
GB0412181D0 (en) Biological products
GB0425569D0 (en) Biological products
HK1095739A1 (en) Skin care composition
EP1863899A4 (fr) Compositions destinées au traitement de la peau
EP1879449A4 (fr) Compositions et procedes de soin de la peau
IL178815A0 (en) The treatment of respiratory disease
PL1750838T3 (pl) Wyroby do palenia zawierające katalizator ze złotem
IL189834A0 (en) Novel skin care compositions
ZA200703107B (en) Novel skin care formulation
ATE405326T1 (de) Kosmetiktuchprodukt
GB0410399D0 (en) The treatment of respiratory disease
ATE389742T1 (de) Gewebebehandlungsmittel
DK1867352T3 (da) Anatomisk implanterbar hjerteprotese i ét stykke
PL1762219T3 (pl) Fotoochronne i/lub fotoimmunoochronne kompozycje do skóry i ich zastosowania
EP1896074A4 (fr) Compositions pharmaceutiques pour traiter ou prevenir une maladie coronarienne
GB0803826D0 (en) Novel therapeutic agent derived from marine organism
IL178127A0 (en) Benzofuranyl derivatives useful for the treatment of cardiac arrhythmia
GB2398740B (en) Skin composition
TJ405B (en) Preparation vitagin for treatment of endometritis of cows.